StocksDeepDive
Snapshot · Russell 3000 · generated 2026-09-19 21:53 UTC

PALI — Palisade Bio, Inc.

UNDERVALUED (MOS +84.6%) · Quality 28/100

Price
1.59
Intrinsic value
10.31
Margin of safety
+84.6%
Implied growth (reverse DCF)
-
a described calculation from stated inputs, not a forecast
Value Score
35
Quality
28
Psychology
28.7
Discovery
45.5
price/volume attention only
Moat score
0
erosion: none

Value Score: top 46% of Russell 3000 · Quality: bottom 15%

Open the interactive Deep Dive for PALI →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/PALI - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is PALI undervalued?

As of 2026-09-19, PALI trades at 1.59 against a computed intrinsic value of 10.31 (+84.6% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Palisade Bio, Inc.'s Value Score?

Palisade Bio, Inc.'s Value Score is 35 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.